documents: FDA-2020-D-1136-0020

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2020-D-1136-0020 FDA FDA-2020-D-1136 Statistical Considerations for Clinical Trials During the COVID-19 Public Health Emergency - Guidance for Industry Other Guidance 2020-06-16T04:00:00Z 2020 6 2020-06-16T04:00:00Z 2023-05-12T03:59:59Z 2023-05-09T19:04:53Z   0 0 09000064846f4ae5

Links from other tables